Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2022-11-10 Interim / Quarterly Rep…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2022
2022-11-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 10, 2022, reporting the results of operations for the third quarter ended September 30, 2022. It references an attached earnings press release (Exhibit 99.1) that contains the financial results. The document itself is a current report announcing the earnings release, not the earnings release or financial report itself. The length is 3381 characters, which is relatively short and consistent with an announcement rather than a full report. According to the classification rules, initial announcements of quarterly financial results are classified as Earnings Release (ER). The document explicitly states it is reporting results of operations and includes an earnings press release. Therefore, the correct classification is Earnings Release (ER).
2022-11-10 English
FORM 4
Director's Dealing
2022-08-31 English
FORM 4
Director's Dealing
2022-08-17 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated August 11, 2022, for Apyx Medical Corporation. The key content is the submission of matters to a vote of security holders at the company's annual meeting, including election of directors, ratification of auditors, and advisory vote on executive compensation. It provides detailed final voting results for each proposal. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. The document length is 4180 characters, which is not extremely short, and it contains substantive voting data, not just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2022-08-17 English
FORM 4
Director's Dealing
2022-08-17 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.